Linked Total Elbow Arthroplasty in Patients with Rheumatoid Arthritis

Published on 11/04/2015 by admin

Filed under Orthopaedics

Last modified 11/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1959 times

CHAPTER 54 Linked Total Elbow Arthroplasty in Patients with Rheumatoid Arthritis


Both coupled and uncoupled elbow replacement prosthetic designs are employed for the management of end-stage rheumatoid arthritis.11,12,43 This chapter reviews the results of the linked, semiconstrained design, primarily that of the Coonrad/Morrey. As noted previously in this text, the clinical and radiologic presentation of inflammatory arthritis in general and rheumatoid arthritis in particular varies considerably (Fig. 54-1). The semiconstrained implant is especially useful in the type III and IV presentations because this design philosophy assesses stability in the face of bone loss and joint laxity2 (Fig 54-2).

When considering the outcome of total elbow arthroplasty, it is helpful to define the expectations of the intervention:

To date, several evaluation systems exist that allow a critical assessment of the elbow when affected by disease and after therapeutic intervention (see Chapter 5). In the past, we employed the Mayo Elbow Performance Score (MEPS) as defined in Table 54-126 and are currently incorporating the measurements of the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire as well.

TABLE 54-1 Mayo Elbow Performance Score*

Function Point Score
Pain (45 points)  
None 45
Mild 30
Moderate 15
Severe 0
Motion (20 points)  
Arc 100 degrees 20
Arc 50 to 100 degrees 15
Arc 2 degrees 5
Stability (10 points)  
Stable 10
Moderate instability  
Gross instability 0
Daily function (25 points)  
Combing hair 5
Feeding oneself 5
Hygiene 5
Putting on shirt 5
Putting on shoes 5
Maximum possible total 100

* 90 points or more = excellent; 75 to 89 points = good; 60 to 74 points = fair; and less than 60 points = poor.

Stable = no apparent varus-valgus laxity clinically; moderate instability = less than 10 degrees of varus-valgus laxity; gross instability = 10 degrees or more of varus-valgus laxity.

Review of the literature reveals improving and encouraging results with several semiconstrained designs (Table 54-2).16 In this chapter, we review several of these experiences and then focus on Mayo’s perspective and outcomes. The outcome of replacement for rheumatoid is superior to that for traumatic arthritis.3


Linked, less constrained designs were introduced in the early 1970s to address problems of early stem loosening attributed to the rigid hinge design. For the most part, the results of these devices were encouraging.


The Pritchard II prosthesis (Fig. 54-3) was an early design introduced in the 1970s as a linked semiconstrained device.32,38,39 Pritchard’s own experience with 92 patients was reported in 1981 and included 55 with rheumatoid arthritis. The mean follow-up was short (2.5 years). Although the range of motion, stability, and measure of function were not reported, relief of pain was reported as 98%.38 A 15% complication rate and 2% loosening requiring revision were recorded.

Subsequently, Madsen and associates32 followed 25 consecutive Pritchard II implants for a mean of 3 years. Twenty-three of 25 patients had relief of pain. The flexion arc averaged 28 to 130 degrees and pronation-supination was 65 to 62 degrees, respectively. Stability was not discussed, but the mean assessment score improved from 40 to 82. However, radiographic loosening occurred in 6 of 24 elbows, and two necessitated revision.

These initial reports of the Pritchard II implant were of small numbers, and their findings were regarded as preliminary.32,38,39 The major problem was wear or fracture of the polyethylene bearing. The device was subsequently modified but is not used to any extent today.


There has been a tendency for wear and dislocation over time; however,13 this articulation has undergone numerous modifications but still allows several degrees of varus-valgus and axial rotation “play” (Fig. 54-4). The implant has been used almost exclusively for patients with rheumatoid arthritis. A customized version has been described for various pathologic states other than rheumatoid arthritis.


This device has also undergone several design modifications, primarily related to the articulation. Stabilization of the fixation is sought by wrapping the implant around the distal aspect of the medial and lateral condyles. The device also allows 2- to 3-mm axial translation. Virtually all of the GSB experience is from Europe.

The current GSB II device provides about 4 degrees of varus-valgus toggle and uniquely some axial translation (Fig. 54-5). The stem is stabilized by medial and lateral flanges that are attached to the condyles. Hence, a requirement of this implant is intact or reconstructed condyles. Experience with the modified implant was reported by Bell and colleagues4 in 1986. Forty-one of 46 patients had relief of pain, and range of motion averaged 29 to 137 degrees. In 1988, Gschwend and associates17

Buy Membership for Orthopaedics Category to continue reading. Learn more here